Study offers a potential strategy to improve T cell therapy in solid tumors
A new approach that delivers a ‘one-two punch’ to help T cells attack solid tumors is the focus of a preclinical study. The findings showed that targeting two regulators that control gene functions related to inflammation led to at least 10 times greater T cell expansion in models, resulting in increased anti-tumor immune activity and durability.
Materials provided by University of Pennsylvania School of Medicine. Note: Content may be edited for style and length.
Source link aaaaa
